Bolt Projects Faces Nasdaq Delisting Amidst Deep Losses, $4.25M PIPE

TL;DR

**Bolt is bleeding cash, facing delisting, and its $4.25 million PIPE is a drop in the bucket for a company with a $472.3 million accumulated deficit — steer clear.**

AI Summary

Bolt Projects Holdings, Inc. (BSLKW) filed an S-1 on August 22, 2025, for the resale of up to 913,979 shares of common stock by selling stockholders, including 518,817 initial shares and up to 395,162 warrant shares. The company reported a net loss of $65.4 million for the year ended December 31, 2024, and a net loss of $10.5 million for the six months ended June 30, 2025, with an accumulated deficit of $472.3 million as of June 30, 2025. Bolt recently completed an August 2025 PIPE Transaction, raising approximately $4.25 million in gross proceeds by selling 913,979 shares at $4.65 per share. Strategically, Bolt discontinued all other product candidates in early 2023 to focus 100% on its Vegan Silk Technology Platform, which includes b-silk and xl-silk for the beauty industry, backed by 80 granted patents. A significant risk is the potential delisting from Nasdaq, as the company received a delisting letter on August 12, 2025, and has a hearing scheduled for September 16, 2025. The company also acknowledges material weaknesses in internal control over financial reporting.

Why It Matters

This S-1 filing reveals Bolt Projects Holdings' precarious financial position, marked by substantial losses and a potential Nasdaq delisting, which could severely impact investor confidence and liquidity for BSLKW shareholders. The company's strategic pivot to focus solely on its Vegan Silk Technology Platform, while aiming for scalability, comes with the high risk of limited product recognition and dependence on a single manufacturing partner. For employees, the ongoing financial instability and delisting threat create job insecurity, while customers might face supply chain risks due to the reliance on a single manufacturing facility. Competitively, Bolt faces an uphill battle against incumbent materials and new entrants, making its path to profitability highly uncertain.

Risk Assessment

Risk Level: high — Bolt Projects Holdings, Inc. has a history of net losses, including $65.4 million in 2024 and $10.5 million in H1 2025, and an accumulated deficit of $472.3 million as of June 30, 2025, raising substantial doubt about its ability to continue as a going concern. Furthermore, the company received a delisting letter from Nasdaq on August 12, 2025, and has identified material weaknesses in its internal control over financial reporting, indicating significant operational and financial instability.

Analyst Insight

Investors should exercise extreme caution and consider avoiding BSLKW shares given the severe financial distress, including substantial losses and accumulated deficit. The imminent threat of Nasdaq delisting and identified material weaknesses in internal controls present significant downside risks that outweigh the potential upside of its Vegan Silk Technology Platform.

Financial Highlights

debt To Equity

Not Disclosed

revenue

Not Disclosed

operating Margin

Not Disclosed

total Assets

Not Disclosed

total Debt

Not Disclosed

net Income

-$65.4M

eps

Not Disclosed

gross Margin

Not Disclosed

cash Position

Not Disclosed

revenue Growth

Not Disclosed

Key Numbers

• $65.4M — Net Loss (For the year ended December 31, 2024, indicating significant unprofitability.)
• $10.5M — Net Loss (For the six months ended June 30, 2025, showing continued losses.)
• $472.3M — Accumulated Deficit (As of June 30, 2025, highlighting substantial historical losses.)
• 913,979 — Shares Offered (Total shares of common stock for resale by Selling Stockholders.)
• $4.65 — Per Share Price (Price at which shares were sold in the August 2025 PIPE Transaction.)
• $4.25M — Gross Proceeds (From the August 2025 PIPE Transaction, before fees.)
• $8.90 — Closing Price (Of common stock on Nasdaq on August 21, 2025.)
• 80 — Granted Patents (Supporting the Vegan Silk Technology Platform.)
• 116 — Pending Patent Applications (Further intellectual property for the Vegan Silk Technology Platform.)
• $300M — Invested in R&D (Over 13 years for biomaterial development.)

Key Players & Entities

• Bolt Projects Holdings, Inc. (company) — Registrant
• BSLKW (company) — Ticker symbol on Nasdaq Global Market
• Daniel Widmaier (person) — Chief Executive Officer of Bolt Projects Holdings, Inc.
• Drew Capurro (person) — Latham & Watkins LLP counsel
• Securities and Exchange Commission (regulator) — Regulatory body for S-1 filing
• Nasdaq Global Market (regulator) — Stock exchange where BSLKW is listed
• Golden Arrow Merger Corp. (company) — Former name of the registrant
• Bolt Threads, Inc. (company) — Wholly-owned subsidiary after Business Combination
• Selling Stockholders (person) — Parties selling shares in the August 2025 PIPE Transaction
• Latham & Watkins LLP (company) — Legal counsel for the registrant

FAQ

Risk Factors

• Nasdaq Delisting Risk [high — regulatory]: Bolt Projects Holdings received a delisting letter from Nasdaq on August 12, 2025, and faces a hearing on September 16, 2025. Failure to regain compliance could result in delisting, significantly impacting liquidity and investor confidence.
• Material Weaknesses in Internal Controls [high — financial]: The company acknowledges material weaknesses in its internal control over financial reporting. This raises concerns about the accuracy and reliability of financial statements, potentially leading to errors and investor distrust.
• Substantial Accumulated Deficit [high — financial]: As of June 30, 2025, Bolt Projects Holdings had an accumulated deficit of $472.3 million. This indicates a long history of unprofitability and significant ongoing cash burn, raising questions about long-term financial viability.
• Dependence on PIPE Financing [medium — financial]: The company recently raised $4.25 million through a PIPE transaction at $4.65 per share. This reliance on external financing, especially at potentially dilutive terms, highlights a need for continuous capital infusion to sustain operations.
• Concentration on Vegan Silk Technology [medium — operational]: Bolt has discontinued all other product candidates to focus 100% on its Vegan Silk Technology Platform. This strategic pivot concentrates all future success and risk on a single technology, increasing vulnerability to market acceptance or technical challenges.
• History of Significant Net Losses [medium — financial]: The company reported a net loss of $65.4 million for the year ended December 31, 2024, and $10.5 million for the six months ended June 30, 2025. These substantial losses underscore the challenge of achieving profitability.

Industry Context

Bolt Projects Holdings operates in the biomaterials sector, specifically focusing on applications within the beauty industry with its Vegan Silk Technology. This niche area is driven by increasing consumer demand for sustainable and ethically sourced ingredients. The competitive landscape likely includes other companies developing novel biomaterials and traditional cosmetic ingredient suppliers adapting to market trends.

Regulatory Implications

The company faces significant regulatory risk related to its Nasdaq listing status, with a hearing scheduled for September 16, 2025, to address potential delisting. Failure to comply with listing requirements could severely impact liquidity and investor access. Additionally, material weaknesses in internal controls necessitate careful scrutiny of financial reporting accuracy.

What Investors Should Do

1. Monitor the outcome of the Nasdaq delisting hearing on September 16, 2025, as delisting would significantly impact liquidity.
2. Assess the company's ability to achieve profitability given its substantial accumulated deficit of $472.3 million and history of net losses.
3. Evaluate the long-term viability and market adoption potential of the Vegan Silk Technology Platform, as it represents the sole focus of the company's R&D efforts.
4. Consider the implications of material weaknesses in internal controls on the reliability of financial reporting and future disclosures.
5. Analyze the dilution impact of future capital raises, given the company's ongoing need for funding and recent PIPE transaction.

Key Dates

• 2023-01-01: Discontinuation of Product Candidates — Marked a strategic shift to focus solely on the Vegan Silk Technology Platform.
• 2025-04-21: 1-for-20 Reverse Stock Split — Adjusted share structure, impacting per-share calculations and potentially signaling efforts to meet exchange listing requirements.
• 2025-08-12: Nasdaq Delisting Letter Received — Indicates non-compliance with Nasdaq listing standards, posing a significant threat to the company's public trading status.
• 2025-08-22: S-1 Filing for Resale of Shares — Provides details on the resale of shares by selling stockholders, including those from a recent PIPE transaction.
• 2025-09-16: Nasdaq Delisting Hearing — Crucial date for determining the company's ability to remain listed on Nasdaq.

Glossary

S-1 Filing

A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. It contains detailed information about the company's business, financial condition, and the securities being offered. (This filing provides the primary source of information for investors regarding the resale of shares and the company's current status.)

PIPE Transaction

Private Investment in Public Equity. A transaction where a private investor buys stock directly from a publicly traded company, often at a discount to the market price. (The recent PIPE transaction indicates the company's need for capital and the terms under which it is being raised.)

Accumulated Deficit

The total cumulative net losses of a company since its inception, minus any cumulative net income. It represents the total amount by which a company's expenses have exceeded its revenues over time. (A large accumulated deficit, like Bolt's $472.3 million, signifies a history of unprofitability and substantial cash burn.)

Material Weakness

A deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. (The presence of material weaknesses raises concerns about the reliability of Bolt's financial reporting.)

Reverse Stock Split

A corporate action in which a company reduces the number of its outstanding shares by consolidating them. For example, a 1-for-20 reverse split means every 20 old shares become 1 new share. (Bolt's 1-for-20 reverse stock split impacts share counts and per-share metrics, and is often done to increase share price to meet exchange listing requirements.)

Year-Over-Year Comparison

This S-1 filing provides an update following the company's strategic pivot to focus solely on its Vegan Silk Technology Platform. Key financial metrics like revenue and net income are not directly comparable to a prior period's filing in this context, as the focus has shifted dramatically. However, the filing highlights a substantial accumulated deficit of $472.3 million as of June 30, 2025, and significant net losses for 2024 ($65.4 million) and the first half of 2025 ($10.5 million), indicating continued financial challenges. A new critical risk factor is the Nasdaq delisting notice received in August 2025, which was not present in prior disclosures.

Key Financial Figures

• $0.0001 — 9 shares of our common stock, par value $0.0001 per share ("common stock") by the selli
• $8.90 — e closing price of our common stock was $8.90 per share. We are an "emerging growth
• $300 million — n 13 years of development and more than $300 million invested in research and product develo
• $65.4 million — of net losses, including a net loss of $65.4 million for the year ended December 31, 2024 an
• $10.5 million — or the year ended December 31, 2024 and $10.5 million for the six months ended June 30, 2025.
• $472.3 million — e 30, 2025, our accumulated deficit was $472.3 million. Moving forward, we are committed to d
• $4.65 — $0.0001 per share ("common stock") for $4.65 per share, consisting of (a) 518,817 sh
• $4.6499 — ). Each Warrant was sold at a price of $4.6499 per Warrant and has an initial exercise
• $4.25 m — 025 PIPE Transaction, was approximately $4.25 million, prior to deducting placement age
• $1.235 billion — h Company As a company with less than $1.235 billion in revenue during our last fiscal year,
• $1.235 b — if (i) our annual gross revenue exceeds $1.235 billion, (ii) we issue more than $1.0 bil
• $1.0 billion — $1.235 billion, (ii) we issue more than $1.0 billion of non-convertible debt in any three-ye
• $700.0 million — ty securities held by non-affiliates of $700.0 million or more as of the last business day of

Filing Documents

• ea0254003-s1_bolt.htm (S-1) — 2784KB
• ea025400301ex5-1_bolt.htm (EX-5.1) — 16KB
• ea025400301ex23-1_bolt.htm (EX-23.1) — 3KB
• ea025400301ex10-39_bolt.htm (EX-10.39) — 78KB
• ea025400301ex-fee_bolt.htm (EX-FILING FEES) — 14KB
• image_001.jpg (GRAPHIC) — 148KB
• ex5-1_001.jpg (GRAPHIC) — 44KB
• 0001213900-25-080008.txt ( ) — 14145KB
• bslk-20250630.xsd (EX-101.SCH) — 130KB
• bslk-20250630_cal.xml (EX-101.CAL) — 77KB
• bslk-20250630_def.xml (EX-101.DEF) — 693KB
• bslk-20250630_lab.xml (EX-101.LAB) — 1091KB
• bslk-20250630_pre.xml (EX-101.PRE) — 713KB
• ea0254003-s1_bolt_htm.xml (XML) — 1848KB
• ea025400301ex-fee_bolt_htm.xml (XML) — 5KB

USE OF PROCEEDS

USE OF PROCEEDS 30 DIVIDEND POLICY 31

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 32

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 62 BENEFICIAL OWNERSHIP 65 SELLING STOCKHOLDERS 67 MANAGEMENT 70 EXECUTIVE AND DIRECTOR COMPENSATION 76 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 84 PLAN OF DISTRIBUTION 87 LEGAL MATTERS 88 EXPERTS 88 WHERE YOU CAN FIND MORE INFORMATION 89 INDEX TO FINANCIAL STATEMENTS F-1 You should rely only on the information contained in this prospectus. No one has been authorized to provide you with information that is different from that contained in this prospectus. This prospectus is dated as of the date set forth on the cover hereof. You should not assume that the information contained in this prospectus is accurate as of any date other than that date. For investors outside the United States: We have not done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus. i CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this prospectus may constitute "forward-looking statements" for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a sta

Use of proceeds

Use of proceeds We will not receive any proceeds from the sale of the Shares by the Selling Stockholders. We have agreed to bear the expenses relating to the registration of the Shares. See "Use of Proceeds" for additional information. Nasdaq symbol for our common stock "BSLK"

Risk factors

Risk factors Any investment in the securities offered hereby is speculative and involves a high degree of risk. You should carefully consider the information set forth under "Risk Factors" and elsewhere in this prospectus. On April 21, 2025, we effected a 1-for-20 reverse stock split of our common stock (the "Reverse Stock Split"). Unless the context expressly indicates otherwise, all references to share and per share amounts referred to herein reflect the amounts after giving effect to the Reverse Stock Split. 5 RISK FACTORS Investing in our securities involves risks. Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed above under "Cautionary Note Regarding Forward-Looking Statements," you should carefully consider the specific risks set forth herein. If any of these risks ac

View Full Filing

View this S-1 filing on SEC EDGAR